ll

Kilitch Drugs (India) Ltd.

April 15, 2022

To,

Department of Corporate Services BSE Limited

P. J. Towers, Dalal Street

Fort, Mumbai - 400

001

Scrip Code: BSE - 524500

Dear Sir/Madam,

To,

Corporate Listing Department National Stock Exchange of India Ltd Exchange Plaza, Plot No.C-1, G Block, BKC, Bandra (E), Mumbai 400 051 Scrip Code: NSE - KILITCH

Sub: Resignation of Company Secretary & Compliance officer

KI

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we inform you that Ms. Princy Asati, Company Secretary & Compliance Officer of the Company has resigned with effect from close of working hours of April 15, 2022.

The company has accepted his resignation and relieved him from his responsibility with effect from close of business hours on April 15, 2022. Her successor shall be appointedshortly and the same

shall be intimated to Stock Exchange(s).

Kindly takethe same on your records.

Thanking You,

Mukund Mehta Managing Director DIN: 00147876

sels Spite nih

iso

SPIES

6) )

LAAs

5

QM Oe,

aseRTH,

Sy

[EER

ne

WHO CERTIFIED

RD

"2D By GOW :

INDIA

4348358:.220003

Pharmacy of the World

Corporate office : 37/39, Ujagar Industrial Estate, W. T. Patil Marg, Deonar, Mumbai - 400 088. « Tel.: +91-22-6121 4100 e Fax : +91-22-6703 1658

Registered Office & Manufacturing unit : C-301/2, M.I.D.C., T.T.C. Industrial Area, Pawane Village, Navi Mumbai - 400 705. Maharashtra.

e CIN: L24239MH1992PLC066718 « Tel.: +91-22-6299 6300 « Fax : +91-22-2768 0912 « E-mail :info@kilitch.com « Website : www.kilitch.com

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Kilitch Drugs (India) Ltd. published this content on 15 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 April 2022 11:30:00 UTC.